Disputed rpoB Mutations in Mycobacterium tuberculosis and Tuberculosis Treatment Outcomes
Sign Up to like & getrecommendations! Published in 2021 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.01573-20
Abstract: Discordant results between genotypic drug susceptibility testing (gDST) and phenotypic DST (pDST) for Mycobacterium tuberculosis isolates with disputed mutations affect rifampin (RIF)-resistant (RR) and multidrug-resistant (MDR) tuberculosis (TB) treatments due to a lack of practical… read more here.
Keywords: treatment outcomes; rpob mutations; mycobacterium tuberculosis; tuberculosis ... See more keywords
Frequency and Type of Disputed rpoB Mutations in Mycobacterium tuberculosis Isolates from South Korea
Sign Up to like & getrecommendations! Published in 2017 at "Tuberculosis and Respiratory Diseases"
DOI: 10.4046/trd.2017.80.3.270
Abstract: Background A disputed rpoB mutation is a specific type of rpoB mutation that can cause low-level resistances to rifampin (RIF). Here, we aimed to assess the frequency and types of disputed rpoB mutations in Mycobacterium… read more here.
Keywords: rpob mutations; south korea; tuberculosis; rpob mutation ... See more keywords